Skip to main content
. 2024 Sep 15;16(9):4967–4978. doi: 10.62347/ARYA8831

Table 2.

Comparison of blood glucose indicators (x̅±sd)

Group 2hPG (mmol/L) FPG (mmol/L) HbA1c (%)



Before Treatment After Treatment Before Treatment After Treatment Before Treatment After Treatment
Early SGLT2-i group (n = 88) 13.52±4.26 7.24±2.21* 8.09±2.56 5.58±1.76* 8.34±2.68 5.12±1.64*
Late SGLT2-i group (n = 90) 13.81±4.02 8.36±2.65* 8.57±2.75 6.24±2.01* 8.69±2.79 6.47±2.05*
t 0.467 3.059 1.205 2.329 0.853 4.845
P 0.641 0.003 0.230 0.021 0.395 < 0.001
*

P < 0.05 compared to pre-treatment within the same group;

FPG, fasting plasma glucose; 2hPG, 2-hour postprandial glucose; HbA1c, glycated hemoglobin; SGLT2-i, sodium-glucose cotransporter 2 inhibitor.